|
|
Comparison of therapeutic effects of Xiaoer Kechuan Granule combined with Budesonide Atomization and simple atomization in the treatment of children with bronchial asthma complicated with pulmonary infection |
XU Han1 ZHANG Fan2 WAN Muyuan3▲ |
1. Department of Pediatrics, Jiangxi Children′s Hospital, Jiangxi Province, Nanchang 330000, China;
2. Department of Respiratory Medicine, Jiangxi Children′s Hospital, Jiangxi Province, Nanchang 330000, China;
3. Department of Pharmacy, Jiangxi Children′s Hospital, Jiangxi Province, Nanchang 330000, China |
|
|
Abstract Objective To compare the curative effect of Xiaoer Kechuan Granule combined with Budesonide Atomization and simple atomization in the treatment of bronchial asthma complicated with pulmonary infection. Methods A total of 80 cases of children with bronchial asthma complicated with pulmonary infection admitted to Jiangxi Children′s Hospital from December 2019 to September 2021 were selected as the research objects, they were divided into the observation group and the control group according to random number table method, with 40 cases in each group. The control group was given Budesonide Atomization treatment, and the observation group was given Xiaoer Kechuan Granule on the basis of the above. The clinical efficacy, symptom improvement (duration of dyspnea, disappearance time of lung moist rales, disappearance time of lung wheezing and cough duration), inflammatory level (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6]) and the incidence of adverse reactions were compared between the two groups. Results The total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). The disappearance time of lung moist rales, disappearance time of lung wheezing and cough duration in the observation group were shorter than those in the control group, and the differences were statistically significant (P<0.05). The level of IL-6 in the observation group after treatment was lower than that before treatment and that in the control group after treatment, and the differences were statistically significant (P<0.05). There was no significance in the total incidence of adverse reactions between two groups (P>0.05). Conclusion Xiaoer Kechuan Granule combined with Budesonide Atomization can improve the clinical efficacy and reduce the level of inflammation in children with bronchial asthma complicated with pulmonary infection, which is safe and worthy of clinical attention.
|
|
|
|
|
[1] |
周庆良,周建林.沙丁胺醇联合布地奈德雾化吸入治疗小儿支气管哮喘合并肺部感染的临床疗效[J].临床合理用药杂志,2018,11(18):68-69.
|
[2] |
李欣怡,余君,朱蕾.大环内酯类抗生素治疗难治性支气管哮喘患者的疗效及安全性[J].中华结核和呼吸杂志,2019,42(1):33-36.
|
[3] |
赵娟.沙丁胺醇与布地奈德雾化吸入对支气管哮喘患者伴有肺部感染的疗效及其对炎症因子水平的影响[J].抗感染药学,2018,15(5):909-911.
|
[4] |
陈竹,彭玉,张立文,等.清气化痰汤治疗小儿痰热壅肺型哮喘的疗效评价[J].贵州医药,2019,43(1):89-91.
|
[5] |
马静维,宫振华.麻杏石甘汤加减结合常规疗法治疗邪热壅肺证支气管哮喘急性发作期的临床研究[J].天津中医药,2019,36(2):148-152.
|
[6] |
中华人民共和国国家健康委员会,国家中医药局.儿童社区获得性肺炎诊疗规范(2019年版)[J].中华临床感染病杂志,2019,12(1):6-13.
|
[7] |
中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童支气管哮喘诊断与防治指南(2016年版)[J].中华儿科杂志,2016,54(3):167-181.
|
[8] |
郑筱萸.中药新药临床研究指导原则:试行[M].北京:中国医药科技出版社,2002:364-366.
|
[9] |
陈祥瑞.硫酸沙丁胺醇联合布地奈德雾化治疗小儿哮喘的临床效果及相关机制分析[J].中国妇幼保健,2018,33(6):1331-1334.
|
[10] |
王琰碧.沙丁胺醇联合布地奈德雾化吸入治疗小儿支气管哮喘合并肺部感染[J].中外医学研究,2017,15(2):106-108.
|
[11] |
白冬梅.小儿咳喘颗粒治疗小儿急性支气管炎40例临床资料报道[J].心理医生,2016,22(8):68-69.
|
[12] |
谢莉莉.小儿肺热咳喘颗粒联合西药治疗小儿毛细支气管炎疗效分析[J].实用中西医结合临床,2021,21(13):40-41.
|
[13] |
王小丽,陈娟.小儿肺咳颗粒联合头孢曲松钠治疗小儿感染后咳嗽疗效及对IFN-γ、CRP的影响[J].中华中医药学刊,2020,38(7):224-227.
|
[14] |
杜文琼,彭小利,朱晓琴,等.小儿肺热清颗粒联合丙酸氟替卡松对小儿支气管哮喘患者的临床疗效[J].中成药,2019,41(2):313-316.
|
[15] |
李莎,舒秀兰.小儿肺热咳喘颗粒联合丙酸氟替卡松治疗小儿支气管哮喘疗效及对IL-6,IL-8及TNF-α水平的影响[J].中华中医药学刊,2021,39(3):237-240.
|
[16] |
刘志刚,柴程芝.基于药性结合药理的麻黄药证研究[J].中国中药杂志,2019,44(18):3883-3889.
|
[17] |
权浩浩,张晓凤,高凯,等.基于网络药理学的僵蚕主要药效作用研究[J].西部中医药,2021,34(3):92-96.
|
[18] |
陈明,吴宸广,田锋,等.基于网络药理学的桑白皮-紫苏子药对治疗慢性肾脏病的作用机制探析[J].中国中西医结合肾病杂志,2021,22(2):136-139,189.
|
[19] |
谢雄雄,张迟,曾金祥,等.中药桔梗的化学成分和药理活性研究进展[J].中医药通报,2018,17(5):66-72,13.
|
[20] |
巴珂,李颖,何文楷,等.不同川贝母制剂镇咳、祛痰和抗炎作用实验研究[J].西南民族大学学报(自然科学版),2018,44(1):52-55.
|
|
|
|